A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
暂无分享,去创建一个
[1] D E Wurster,et al. Dissolution kinetics of certain crystalline forms of prednisolone. , 1965, Journal of pharmaceutical sciences.
[2] H. Vromans,et al. Biowaivers for Oral Immediate-Release Products , 2004, Clinical pharmacokinetics.
[3] J. Cloyd,et al. Reduced seizure control due to spoiled phenytoin capsules , 1980, Annals of neurology.
[4] Jennifer B Dressman,et al. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[5] James C. Sexton,et al. Computational fluid dynamics modeling of the paddle dissolution apparatus: Agitation rate, mixing patterns, and fluid velocities , 2004, AAPS PharmSciTech.
[6] Gordon L. Amidon,et al. Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.
[7] Michael Weiss,et al. Does the Dose-Solubility Ratio Affect the Mean Dissolution Time of Drugs? , 2004, Pharmaceutical Research.
[8] Panos Macheras,et al. Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches , 2005 .
[9] Panos Macheras,et al. Gastrointestinal Drug Absorption: Is It Time to Consider Heterogeneity as Well as Homogeneity? , 1997, Pharmaceutical Research.
[10] S. Pedersen,et al. Erratic absorption of a slow-release theophylline sprinkle product. , 1984, Pediatrics.
[11] Michael A. Koupparis,et al. Dissolution of 4 controlled-release theophylline formulations in milk , 1987 .
[12] G. Amidon,et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. , 2004, Molecular pharmaceutics.
[13] E NELSON,et al. Inactive prednisone tablets U.S.P. XVI. , 1963, Journal of pharmaceutical sciences.
[14] Vinod P. Shah,et al. Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.
[15] Alexander T. Florence,et al. Solubilization by surface-active agents and its applications in chemistry and the biological sciences , 1968 .
[16] P. Pentikäinen,et al. Effect of particle size on the bioavailability of digoxin , 1975, European Journal of Clinical Pharmacology.
[17] W. L. Chiou,et al. Mechanism of increased rates of dissolution and oral absorption of chloramphenicol from chloramphenicol-urea solid dispersion system. , 1971, Journal of pharmaceutical sciences.
[18] P. Maturu,et al. Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vitro demonstration of an in vivo observation. , 1986, Journal of pharmaceutical sciences.
[19] Walter Schmitt,et al. A physiological model for the estimation of the fraction dose absorbed in humans. , 2004, Journal of medicinal chemistry.
[20] W. G. Lloyd,et al. Diffusion in glassy polymers , 2007 .
[21] Sophia G. Antimisiaris,et al. An in vitro model for exploring CR theophylline-milk fat interactions , 1989 .
[22] E NELSON,et al. Solution rate of theophylline salts and effects from oral administration. , 1957, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.
[23] K. Kosmidis,et al. On the use of the Weibull function for the discernment of drug release mechanisms. , 2006, International journal of pharmaceutics.
[24] Mei-Ling Chen,et al. Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities. , 2004, Journal of pharmaceutical sciences.
[25] G. Levy,et al. Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals. , 1963, American journal of pharmacy and the sciences supporting public health.
[26] Panos Macheras,et al. The Mean Dissolution Time Depends on the Dose/Solubility Ratio , 2003, Pharmaceutical Research.
[27] W. Schmitt,et al. A Physiologic Model for Simulating Gastrointestinal Flow and Drug Absorption in Rats , 2003, Pharmaceutical Research.
[28] D C Hohnadel,et al. Effect of calcium and antacids on phenytoin bioavailability. , 1979, Archives of neurology.
[29] A B Varley,et al. The generic inequivalence of drugs. , 1968, JAMA.
[30] V. T. Stannett,et al. Effect of particle size on the mechanism controlling n-hexane sorption in glassy polystyrene microspheres , 1977 .
[31] P. V. Danckwerts. Significance of Liquid-Film Coefficients in Gas Absorption , 1951 .
[32] L. J. Edwards. The dissolution and diffusion of aspirin in aqueous media , 1951 .
[33] G. Amidon,et al. Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.
[34] Anette Müllertz,et al. Dissolution of Hydrocortisone in Human and Simulated Intestinal Fluids , 2000, Pharmaceutical Research.
[35] Juergen Siepmann,et al. A New Mathematical Model Quantifying Drug Release from Bioerodible Microparticles Using Monte Carlo Simulations , 2002, Pharmaceutical Research.
[36] Ajaz S. Hussain,et al. The Effect of In Vivo Dissolution, Gastric Emptying Rate, and Intestinal Transit Time on the Peak Concentration and Area-Under-the-Curve of Drugs with Different Gastrointestinal Permeabilities , 2004, Pharmaceutical Research.
[37] A. Noyes,et al. The rate of solution of solid substances in their own solutions , 1897 .
[38] Susumu Miyamoto,et al. A theory of the rate of solution of solid into liquid , 1932 .
[39] V. Shah,et al. Phenytoin II: in vitro-in vivo bioequivalence standard for 100-mg phenytoin sodium capsules. , 1983, Journal of pharmaceutical sciences.
[40] Nicholas A. Peppas,et al. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .
[41] Vinod P. Shah,et al. Importance of media selection in establishment of in vitro-in vivo relationships for quinidine gluconate , 1982 .
[42] Michael Levin. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .
[43] Panos Macheras,et al. Quantitative Biopharmaceutics Classification System: The Central Role of Dose/Solubility Ratio , 2003, Pharmaceutical Research.
[44] L Hendeles,et al. Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. , 1985, Chest.
[45] Shlomo Havlin,et al. On controlled diffusion‐limited drug release from a leaky matrix , 1985 .
[46] F Langenbucher,et al. Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution , 1972, The Journal of pharmacy and pharmacology.
[47] Harold Boxenbaum,et al. Absorption Potential and Its Variants , 1999, Pharmaceutical Research.
[48] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[49] Meyer Wildermann,et al. Über die Geschwindigkeit molekularer und chemischer Reaktionen in heterogenen Systemen. Erster Teil. , 1909 .
[50] Mehran Yazdanian,et al. The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs , 2004, Pharmaceutical Research.
[51] T. Higuchi,et al. Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.
[52] Samuel H. Yalkowsky,et al. A Simple Modified Absorption Potential , 2001, Pharmaceutical Research.
[53] F. Bochner,et al. Factors involved in an outbreak of phenytoin intoxication. , 1972, Journal of the neurological sciences.
[54] M. Mellow,et al. Variation in biologic availability of digoxin from four preparations. , 1971, The New England journal of medicine.
[55] M. Eadie,et al. Outbreak of Anticonvulsant Intoxication in an Australian City* , 1970, British medical journal.
[56] Hans Lennernäs,et al. The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.
[57] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[58] A. Healy,et al. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability , 2005, The Journal of pharmacy and pharmacology.
[59] M. Gibaldi,et al. Rate of Dissolution of Griseofulvin and Hexoestrol in Bile Salt Solutions , 1966, Nature.
[60] C. Hagemeir,et al. A unified mathematical model for diffusion from drug-polymer composite tablets. , 1976, Journal of biomedical materials research.
[61] Erich Brunner,et al. Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .
[62] J. M. Cook,et al. The fractal approach to heterogeneous chemistry , 1990 .
[63] Panos Macheras,et al. Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples , 2004, Pharmaceutical Research.
[64] R. Löbenberg,et al. Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.
[65] G LEVY. EFFECT OF DOSAGE FORM PROPERTIES ON THERAPEUTIC EFFICACY OF TOLBUTAMIDE TABLETS. , 1964, Canadian Medical Association journal.
[66] N. Peppas. Analysis of Fickian and non-Fickian drug release from polymers. , 1985, Pharmaceutica acta Helvetiae.
[67] W. Nernst,et al. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .
[68] D. F. Evans,et al. Accelerating gallstone dissolution. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[69] L. Bruner,et al. Über die Auflösungsgeschwindigkeit fester Körper , 1900 .
[70] J. Ruedy,et al. Comparative bioavailability of three brands of ampicillin. , 1972, Canadian Medical Association journal.
[71] D E WURSTER,et al. Investigation of drug release from solids. IV. Influence of adsorption on the dissolution rate. , 1961, Journal of pharmaceutical sciences.
[72] Gerhard Levy,et al. Studies on Inactive Prednisone Tablets, U.S.P. XVI , 1964 .
[73] M Gibaldi,et al. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. , 1967, Journal of pharmaceutical sciences.
[74] Vinod P. Shah,et al. In Vitro Topographical Characterization as a Predictor of in Vivo Controlled Release Quinidine Gluconate Bioavailability , 1986 .
[75] Anne Marie Healy,et al. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[76] Lutz Trahms,et al. Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. , 2005, Advanced drug delivery reviews.
[77] E. Rinaki,et al. The power law can describe the 'entire' drug release curve from HPMC-based matrix tablets: a hypothesis. , 2003, International journal of pharmaceutics.
[78] J. W. Poston,et al. BIOAVAILABILITY OF DIGOXIN , 1972 .
[79] A. Dokoumetzidis,et al. Analysis of Dissolution Data Using Modified Versions of Noyes–Whitney Equation and the Weibull Function , 2006, Pharmaceutical Research.
[80] F Theeuwes,et al. Dosage form index: an objective criterion for evaluation of controlled-release drug delivery systems. , 1977, Journal of pharmaceutical sciences.
[81] J. H. G. Jonkman,et al. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet , 2004, European Journal of Clinical Pharmacology.
[82] J. Siepmann,et al. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001 .
[83] P. Macheras,et al. Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. , 1989, Biopharmaceutics & drug disposition.
[84] Blythe Rh,et al. The formulation and evaluation of enteric coated aspirin tablets. , 1959 .
[85] S. Pedersen,et al. Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food. , 1981, British journal of clinical pharmacology.
[86] A. B. Morrison,et al. TABLET DISINTEGRATION AND PHYSIOLOGICAL AVAILABILITY OF DRUGS. , 1965, Journal of pharmaceutical sciences.
[87] Panos Macheras,et al. Fractal kinetics in drug release from finite fractal matrices , 2003 .
[88] James C. Sexton,et al. Simulating the hydrodynamic conditions in the united states pharmacopeia paddle dissolution apparatus , 2008, AAPS PharmSciTech.
[89] A. W. Hixson,et al. Dependence of Reaction Velocity upon surface and Agitation , 1931 .
[90] Panos Macheras,et al. A Reappraisal of Drug Release Laws Using Monte Carlo Simulations: The Prevalence of the Weibull Function , 2003, Pharmaceutical Research.
[91] J. Siepmann,et al. Effect of the size of biodegradable microparticles on drug release: experiment and theory. , 2004, Journal of controlled release : official journal of the Controlled Release Society.